---
document_datetime: 2023-09-21 18:07:20
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/potactasol-epar-all-authorised-presentations_en.pdf
document_name: potactasol-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7357322
conversion_datetime: 2025-12-25 01:24:17.853971
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form                              | Route of Administration   | Packaging    | Content (concentration)   | Package size   |
|-----------------|-----------------|------------|--------------------------------------------------|---------------------------|--------------|---------------------------|----------------|
| EU/1/10/660/001 | Potactasol      | 1 mg       | Powder for concentrate for solution for infusion | Intravenous use           | vial (glass) | 1 mg (1 mg/ml)            | 1 vial         |
| EU/1/10/660/002 | Potactasol      | 4 mg       | Powder for concentrate for solution for infusion | Intravenous use           | vial (glass) | 4 mg (1 mg/ml)            | 1 vial         |